Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M80,939Revenue $M9,260Net Margin (%)8.6Altman Z-Score1.6
Enterprise Value $M110,426EPS $2.4Operating Margin %23.6Piotroski F-Score5
P/E(ttm)112Beneish M-Score-2.2Pre-tax Margin (%)11.0Higher ROA y-yY
Price/Book13.410-y EBITDA Growth Rate %10.5Quick Ratio1.2Cash flow > EarningsY
Price/Sales9.75-y EBITDA Growth Rate %55.9Current Ratio1.5Lower Leverage y-yN
Price/Free Cash Flow47.9y-y EBITDA Growth Rate %119ROA % (ttm)2.4Higher Current Ratio y-yN
Dividend Yield %--PEG2.0ROE % (ttm)14.1Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M343ROIC % (ttm)6.2Gross Margin Increase y-yY

Gurus Latest Trades with VRX

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
VRXJohn Paulson 2015-06-30 Add7.33%$197.39 - $241.73
($221.34)
$ 236.127%Add 339.02%9,000,000
VRXLou Simpson 2015-06-30 Reduce-1.16%$197.39 - $241.73
($221.34)
$ 236.127%Reduce 8.97%1,728,265
VRXWallace Weitz 2015-06-30 Reduce-1.08%$197.39 - $241.73
($221.34)
$ 236.127%Reduce 21.86%716,730
VRXGlenn Greenberg 2015-06-30 Reduce-1.07%$197.39 - $241.73
($221.34)
$ 236.127%Reduce 2.99%5,701,010
VRXSteve Mandel 2015-06-30 Reduce-0.2%$197.39 - $241.73
($221.34)
$ 236.127%Reduce 4.66%5,310,143
VRXRuane Cunniff 2015-06-30 Reduce-0.19%$197.39 - $241.73
($221.34)
$ 236.127%Reduce 0.60%33,884,050
VRXPrivate Capital 2015-06-30 Add0.17%$197.39 - $241.73
($221.34)
$ 236.127%Add 2.50%302,715
VRXChris Davis 2015-06-30 Reduce-0.08%$197.39 - $241.73
($221.34)
$ 236.127%Reduce 6.12%1,762,238
VRXFirst Eagle Investment 2015-06-30 Reduce-0.06%$197.39 - $241.73
($221.34)
$ 236.127%Reduce 11.45%1,055,332
VRXGeorge Soros 2015-06-30 Buy 0.02%$197.39 - $241.73
($221.34)
$ 236.127%New holding9,254
VRXJoel Greenblatt 2015-06-30 Reduce-0.01%$197.39 - $241.73
($221.34)
$ 236.127%Reduce 6.64%61,178
VRXKen Fisher 2015-06-30 Buy $197.39 - $241.73
($221.34)
$ 236.127%New holding1,828
VRXBill Ackman 2015-03-31 Buy 25.84%$142.83 - $204.69
($177.4)
$ 236.1233%New holding19,473,933
VRXWallace Weitz 2015-03-31 Reduce-1.84%$142.83 - $204.69
($177.4)
$ 236.1233%Reduce 33.46%917,261
VRXSteve Mandel 2015-03-31 Reduce-1.62%$142.83 - $204.69
($177.4)
$ 236.1233%Reduce 32.50%5,569,460
VRXJohn Paulson 2015-03-31 Add1.6%$142.83 - $204.69
($177.4)
$ 236.1233%Add 293.70%2,050,000
VRXGlenn Greenberg 2015-03-31 Reduce-1.24%$142.83 - $204.69
($177.4)
$ 236.1233%Reduce 4.07%5,877,016
VRXGeorge Soros 2015-03-31 Sold Out -0.95%$142.83 - $204.69
($177.4)
$ 236.1233%Sold Out0
VRXChris Davis 2015-03-31 Reduce-0.74%$142.83 - $204.69
($177.4)
$ 236.1233%Reduce 46.50%1,877,040
VRXLou Simpson 2015-03-31 Add0.71%$142.83 - $204.69
($177.4)
$ 236.1233%Add 5.81%1,898,540
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

VRX is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


VRX: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Farmer Ronald HaroldDirector 2015-08-26Buy500$2207.33view
Farmer Ronald HaroldDirector 2015-08-21Buy1,000$224.974.96view
Rosiello Robert L.EVP, CFO 2015-07-31Buy7,875$254.28-7.14view
Rosiello Robert L.Executive Vice President 2015-06-12Buy12,900$232.511.55view
UBBEN JEFFREY W 2015-06-10Sell4,200,000$220.247.21view
Farmer Ronald HaroldDirector 2015-06-09Buy1,000$260.63-9.4view
Mirovsky PavelEVP, Pres. & GM Valeant EMENA 2015-06-02Sell38,000$238.01-0.79view
Whitaker Anne ClemDirector 2015-05-26Buy7,500$234.670.62view
Chai-Onn Robert RoswellEVP, CLO, General Counsel 2015-05-04Sell90,938$222.546.1view
Chai-Onn Robert RoswellEVP, CLO, General Counsel 2015-03-02Sell90,939$200.0118.05view

Quarterly/Annual Reports about VRX:

News about VRX:

Articles On GuruFocus.com
Sequoia Fund Comments on Valeant Pt. II Aug 28 2015 
Sequoia Fund Comments on Valeant Pharmaceuticals Aug 27 2015 
Ruane, Cunniff & Goldfarb Investor Day 2015 Transcript Part I Aug 27 2015 
Kyle Bass Focuses on Fuel, Pharmaceutical Stocks in Second Quarter Aug 24 2015 
Valeant Pharmaceuticals' New Female Drug Aug 20 2015 
Meson Capital 2Q Letter Aug 19 2015 
First Eagle Fund Of America 2Q Commentary Aug 11 2015 
First Eagle Overseas Fund Q2 Commentary Aug 03 2015 
Mandel’s Lone Pine Takes Stake in Growing Horizon Pharma Jul 28 2015 
Gabelli ABC Fund Second Quarter Letter Jul 27 2015 

More From Other Websites
4 IBD 50 Drugmakers Getting Lift From New Treatments Aug 29 2015
Summer M&A Market Sizzles on Pharmaceutical Moves Aug 28 2015
Ackman Still Confident Herbalife Ltd. (HLF) Will Fall; Discusses Mondelez International Inc (MDLZ),... Aug 28 2015
Contact lens makers see their day in court Aug 27 2015
Valeant Pharmaceuticals (VRX) Charts Read Like a Textbook Bull Aug 26 2015
Gilead Leads 4 Drugmakers In Top Sector Performers Aug 25 2015
Lou Simpson Boosts Stake in Charles Schwab Aug 25 2015
Top 10 Funds & Stocks at Risk of Being Squeezed in Market Turmoil Aug 25 2015
VALEANT PHARMACEUTICALS INTERNATIONAL, INC. Files SEC form 8-K, Change in Directors or Principal... Aug 25 2015
Valeant Pharmaceuticals Announces The Addition Of D. Robert Hale To Its Board Of Directors Aug 25 2015
Valeant Pharmaceuticals Announces The Addition Of D. Robert Hale To Its Board Of Directors Aug 25 2015
Valeant Pharmaceuticals Announces The Addition Of D. Robert Hale To Its Board Of Directors Aug 25 2015
10 Stocks Billionaire John Paulson Is Buying in 2015 Aug 24 2015
Valeant (VRX) Is in Oversold Territory: What's Next? Aug 24 2015
Apple and 4 Other Stocks Hedge Funds Hated Last Quarter Aug 24 2015
Fortune Live for August 21, 2015: Fastest-Growing Companies, Change the World, and Hain Celestial Aug 21 2015
5 Stocks Hedge Funds Loved in the Second Quarter Aug 21 2015
Valeant Pharmaceuticals acquires Sprout Pharmaceuticals Aug 21 2015

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

User Comments

No comment yet
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK